David Alan Campbell Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 20 hours ago
David Alan Campbell has an estimated net worth of at least $15.6 million*, as of March 19, 2025. They own 293,054 shares of JANX stock. They have sold 120,000 shares of JANX stock since 2021, for an estimated $6.5 million.
David Alan Campbell $JANX SEC Form 4 Insider Trading
David Alan Campbell has filed a total of 10 insider trades in $JANX since 2021. Their most recent trade was a sale of 5,000 shares, made on Jan 07, 2025. Their largest trade was a sale of 25,000 shares, made on Dec 24, 2024. We estimate that they now own 293,054 shares of $JANX, worth an estimated $9.1 million.
Insider Trading at $JANX
There have been a total of 107 insider trades reported at $JANX since 2021, with 11.4 million shares purchased and 7.8 million shares sold. The most active insider traders in $JANX stock have been Andrew Hollman Meyer, David Alan Campbell, and Tighe Reardon. The most recent trade was a purchase of 37,455 shares reported by CAPITAL MANAGEMENT, L.P. RA (None), made on Mar 05, 2025.
History of Insider Stock Trades by David Alan Campbell
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
JANX
|
Sale | 5,000 | Jan 07, 2025 | Jan. 8, 2025, 9 p.m. |
|
JANX
|
Sale | 25,000 | Dec 24, 2024 | Dec. 27, 2024, 9 p.m. |
|
JANX
|
Sale | 15,000 | Dec 03, 2024 | Dec. 3, 2024, 9 p.m. |
|
JANX
|
Sale | 6,719 | Nov 25, 2024 | Nov. 27, 2024, 9 p.m. |
|
JANX
|
Sale | 18,281 | Nov 25, 2024 | Nov. 27, 2024, 9 p.m. |
|
JANX
|
Sale | 11,103 | Oct 28, 2024 | Oct. 30, 2024, 7:30 p.m. |
|
JANX
|
Sale | 13,897 | Oct 28, 2024 | Oct. 30, 2024, 7:30 p.m. |
|
JANX
|
Sale | 18,957 | Sep 27, 2024 | Sept. 27, 2024, 7:30 p.m. |
|
JANX
|
Sale | 795 | Sep 27, 2024 | Sept. 27, 2024, 7:30 p.m. |
|
JANX
|
Sale | 5,248 | Sep 27, 2024 | Sept. 27, 2024, 7:30 p.m. |
$JANX Executives and Stock Owners with Insider Trades
-
Andrew Hollman Meyer, Chief Business Officer
-
David Alan Campbell, President and CEO
-
Tighe Reardon, Acting Chief Financial Officer
-
Thomas Diraimondo, Chief Scientific Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.